Serial Measurement of Capillary Blood Lactate in the Management of Sepsis

• Conditions: Sepsis

• Registration Number: NCT02180399
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Determination of capillary lactate by using "point-of-care" technique is accessible, fast and allows to quantify the circulatory and metabolic dysfunction caused by sepsis. Compared to conventional assay techniques in arterial blood, capillary assay technique may have an increased susceptibility to metabolic alterations induced by sepsis in its initial stages. This increased sensitivity is not necessarily relevant in the management of the most serious patients for whom the diagnosis is obvious, but it could be very useful in patients for whom a diagnosis of severe sepsis or shock have not yet been adopted, particularly to help better identify patients who would require intensive management and avoid the installation of these serious disorders.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02
• Study First Submitted: 2014-02-05
• Study First Submitted QC: 2014-06-30
• Study First Posted: 2014-07-02
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-18
• Last Update Posted: 2017-05-19
• Primary Completion: 2017-09
• Study Completion: 2017-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age ≥ 18 years

• Installation without any plausible explanation of at least one of the following clinical criteria:

  • Chills, fever, mottling, respiratory rate> 20/min; Sat02 < 90% or > 94% with more than 4l O2, heart rate > 90/min,systolic blood pressure < 100 mmHg or 40 mmHg lower compared with normal values, Glasgow coma score < 14. or: .a combination of two (or more) of clinical and laboratory criteria for sepsis.

• Signed informed consent form

Exclusion Criteria

• Need in its current treatment of aerosol administration of beta agonists at a frequency greater than one per 8 hours;
• Targeted therapeutic measures have already stated for more than 60 minutes;
• Diagnosis other than Sepsis;
• Malignant neoplasm or other progressive disease and expected survival was less than 3 months.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
measurement of capillary blood lactate	72 hours after inclusion

Trial Locations

Locations (2)

Service de Médecine Interne - Clinique Médicale B; 🇫🇷 Strasbourg, France

SERVICE DE MED. INTERNE - DIABETE ET MALADIES METABOLIQUES, 1-place de l'Hôpital; 🇫🇷 Strasbourg, France